ARTICLE | Company News
RetroSense Therapeutics ophthalmic, gene/cell therapy news
February 20, 2012 8:00 AM UTC
RetroSense received a $250,000 grant from the Foundation Fighting Blindness to develop a gene therapy technology to ophthalmic indications. Last October, Wayne State University granted the company exc...